TickerFacts.

AEON Biopharma, Inc. (AEON): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$55.03M
As of 2025-12-31
-$15.36M
As of 2026-06-30
2022-12-31: -$270.41M2023-07-21: -$310.82M2023-12-31: -$153.04M2024-12-31: -$28.57M2025-12-31: -$55.03M-$55.03M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$55.03Mn/m2026-03-30, Balance as of period end
2024-12-31-$28.57Mn/m2026-03-30, Balance as of period end
2023-12-31-$153.04Mn/a2025-03-24, Balance as of period end
2023-07-21-$310.82Mn/a2025-03-24, Balance as of period end
2022-12-31-$270.41Mn/a2024-05-14, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
AEON Biopharma, Inc. (AEON)2025-12-31-$55.03Mn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$1.83Mn/m
CDT Equity Inc. (CDT)2025-12-31-$7.17Mn/m
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$3.46M-14.2%
Quantum Cyber N.V. (QUCY)2025-12-31$641.6K-89.3%
Ernexa Therapeutics Inc. (ERNA)2025-12-31$2.40M+41.2%
Polaryx Therapeutics, Inc. (PLYX)2025-12-31$4.57M-3.1%
Petros Pharmaceuticals, Inc. (PTPI)2025-12-31$2.87Mn/m
Enveric Biosciences, Inc. (ENVB)2025-12-31$4.18M+162.3%

Compare AEON, JUNS, CDT, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗